Artgen Biotech PJSC (MIC:ABIO) Book Value per Share : ₽5.14 (As of Jun. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Artgen Biotech PJSC Book Value per Share?

Artgen Biotech PJSC's book value per share for the quarter that ended in Jun. 2023 was ₽5.14.

During the past 12 months, Artgen Biotech PJSC's average Book Value Per Share Growth Rate was 36.50% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 41.40% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 58.70% per year. During the past 10 years, the average Book Value Per Share Growth Rate was -6.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Artgen Biotech PJSC was 186.10% per year. The lowest was -54.60% per year. And the median was 18.40% per year.

Artgen Biotech PJSC's current price is ₽92.02. Its book value per share for the quarter that ended in Jun. 2023 was ₽5.14. Hence, today's PB Ratio of Artgen Biotech PJSC is 22.02.

During the past 13 years, the highest P/B Ratio of Artgen Biotech PJSC was 51.41. The lowest was 1.95. And the median was 13.55.

Artgen Biotech PJSC Book Value per Share Historical Data

The historical data trend for Artgen Biotech PJSC's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Artgen Biotech PJSC Book Value per Share Chart

Artgen Biotech PJSC Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Book Value per Share

Get a 7-Day Free Trial

0.36

1.48

2.59

3.20

4.18

Artgen Biotech PJSC Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Book Value per Share	Get a 7-Day Free Trial															2.98	3.20	3.76	4.18	5.14

Competitive Comparison of Artgen Biotech PJSC's Book Value per Share

For the Biotechnology subindustry, Artgen Biotech PJSC's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Artgen Biotech PJSC's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Artgen Biotech PJSC's PB Ratio distribution charts can be found below:

* The bar in red indicates where Artgen Biotech PJSC's PB Ratio falls into.

Artgen Biotech PJSC Book Value per Share Calculation

Artgen Biotech PJSC's Book Value Per Share for the fiscal year that ended in Dec. 2022 is calculated as:

Book Value Per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(341	-	0)	/	82
	=	4.18

Artgen Biotech PJSC's Book Value Per Share for the quarter that ended in Jun. 2023 is calculated as:

Book Value Per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(381	-	0)	/	74
	=	5.14

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.

Artgen Biotech PJSC (MIC:ABIO) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.

Artgen Biotech PJSC Book Value per Share Related Terms

Thank you for viewing the detailed overview of Artgen Biotech PJSC's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Artgen Biotech PJSC (MIC:ABIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Artgen Biotech PJSC (MIC:ABIO) » Definitions » Book Value per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

Prospect of the 60th Anniversary, Moscow, RUS, 117036

Website

https://www.hsci.ru

Artgen Biotech PJSC formerly Human Stem Cells Institute PJSC is a biotechnology company. It is engaged in the drug discovery, research and development and marketing of proprietary products and services in the field of regenerative medicine, bio-insurance, medical genetics, including reproductive genetics, gene therapy, and biopharmaceutics. The company has developed Neovasculgen, which is a gene therapy drug for the treatment of Peripheral Arterial Disease, including Critical Limb Ischemia and also develops SPRS therapy which entails the use of autologous dermal fibroblasts to repair skin damage due to aging and other structural changes.